NCT00576654
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: BRCA+
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Phase 1
Drug Category: Misc Inhibitor

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Senior)
Location of Metastases: 
Additional Notes: Only BRCA+ TNBC patients will be eligible for phase 2
Exclusions: Patients with known active brain metastases- see trial for details 
https://ClinicalTrials.gov/show/NCT00576654